Researcher
Evy Vandemeulebroucke
- Keywords:Medicine
- Disciplines:Translational sciences, Clinical sciences, Basic sciences
Affiliations
- Pathology/molecular and cellular medicine (Department)
Member
From1 Jan 2014 → 30 Sep 2014 - Internal Medicine Specializations (Department)
Member
From1 Oct 2011 → 31 Dec 2013 - Diabetes Pathology & Therapy (Research group)
Member
From2 Feb 2011 → 30 Sep 2014 - Department of Bio-engineering Sciences (Department)
Member
From1 Jan 2008 → 31 Mar 2008 - Department of Bio-engineering Sciences (Department)
Member
From1 Jan 2003 → 31 Dec 2007 - Ultrastructure (Research group)
Member
From1 Oct 2002 → 1 Jan 2010 - Pathologic Biochemistry and Physiology (Department)
Member
From1 Sep 2000 → 30 Sep 2004 - Structural Biology Brussels (Research group)
Member
From1 Jan 2000 → 1 Jan 2009
Publications
1 - 10 of 15
- Recurrent severe thiamine deficiency following bariatric surgery in pregnant women(2023)
Authors: S. Safraoui, C. Brenez, Sylvie De Raedt, E. Vandemeulebroucke, K. Decochez, G. Lefèvre, Sara Derisbourg, C. Daelemans, An Vercoutere
Pages: 123-126 - Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes(2015)
Authors: Annelien Van Dalem, Simke Demeester, Eric V Balti, K. Decochez, Ilse Weets, E. Vandemeulebroucke, An Walgraeve, Nicole Seret, Christophe De Block, Johannes Ruige, et al.
Pages: 2753-2764 - Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients(2015)
Authors: Eric V Balti, E. Vandemeulebroucke, Ilse Weets, Annelien Van Dalem, Simke Demeester, Katrijn Verhaeghen, Pieter Gillard, Christophe De Block, Johannes Ruige, Bart Keymeulen, et al.
Pages: 551-560 - In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions(2013)
Authors: Eric Mbunwe, P. Van Crombrugge, L. Crenier, M. Coeckelberghs, N. Seret, K. Decochez, E. Vandemeulebroucke, Christiaan Van Schravendijk, J. Wenzlau, J.c. Hutton
Pages: 1964-1970 - Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients(2011)
Authors: Gonnie M Alkemade, E. Vandemeulebroucke, H. Waldmann, C. Mathieu, B. Roep
Pages: 925-927 - Posttransplantation Diabetes Mellitus: A Long-Term Retrospective Cohort Study(2010)
Authors: Mandelina Allamani, Jacques Sennesael, E. Vandemeulebroucke
Pages: 4378-4383 - Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in
the treatment of type 1 diabetes.(2010)
Authors: Geoff Hale, Peppy Rebello, Ibrahim Al Bakir, Emma Bolam, Pawel Wiczling, William J Jusko, E. Vandemeulebroucke, Chantal Mathieu, Annette-G Ziegler, Lucienne Chatenoud, et al.
Pages: 1238-1248 - Structure and mechanism of the 6-oxopurine nucleosidase from Trypanosoma brucei brucei.(2010)
Authors: E. Vandemeulebroucke, C. Minici, I Bruno, L. Muzzolini, P Tornaghi, David Parkin, Wim Versées, Jan Steyaert, M. Degano
Pages: 8999-9010 - Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.(2010)
Authors: M Walter, Chantal Mathieu, E. Vandemeulebroucke, L. Crenier, C. De Block, S Candon, H. Waldmann, A.g. Ziegler, Lucienne Chatenoud
Pages: 614-623 - Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.(2010)
Authors: S Candon, Samira Fafi_kremer, Anette Ziegler, Marianne Leruez-Ville, Chantal Mathieu, E. Vandemeulebroucke, Markus Walter, L. Crenier, Eric Thervet, Christophe Legendre, et al.
Pages: 1145-1155